EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phase-Specific Nutritional Therapy in Critical Illness: When Protein May Help and When It May Harm, from Acute Metabolic Adaptation to Post-ICU Recovery

Mircea Stoian iD, Adina Stoian iD, Claudia Bănescu iD, Sergio Rares Bandilă Bandilă iD, Alina Danilesco, Hajnal Finta, Leonard Azamfirei iD

Nutrients · 29.08.2026 · 18 (17) · 2840

DOI: 10.3390/nu18172840 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 29.08.2026. Verfasst von Mircea Stoian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Intensive Care Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș,…. Hauptthemen laut MEDLINE: Critical Illness, Dietary Proteins, Nutritional Support, Critical Care. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Nutritional support in critically ill patients remains one of the most debated aspects of intensive care medicine. Although international guidelines have long recommended early nutritional support with progressive protein delivery, recent clinical evidence has questioned the benefit of aggressive early calorie and protein provision during the acute phase of critical illness, highlighting the need for phase-adapted nutritional strategies.

Methods

This narrative review summarizes current evidence on individualized, phase-adapted nutritional therapy in critically ill adults and post-ICU survivors, focusing on protein dose and timing, anabolic resistance, muscle wasting, and nutritional management during recovery. Relevant studies published between January 2011 and June 2026 were identified through structured searches of PubMed/MEDLINE, supplemented by reference screening and forward citation tracking. A total of 59 publications were included in the final narrative synthesis.

Results

Recent clinical trials indicate that early high-dose protein administration does not consistently improve survival or functional outcomes and may be associated with harm in selected patient subgroups, particularly those with acute kidney injury, severe organ dysfunction, or shock. More conservative early calorie and protein delivery during the early acute phase has been associated with improved gastrointestinal tolerance and faster clinical stabilization without increasing mortality. Complementary mechanistic evidence supports these findings, highlighting persistent endogenous energy production, anabolic resistance, impaired protein utilization, and reduced autophagy during early critical illness. In contrast, the post-ICU recovery phase is characterized by ongoing muscle wasting, weakness, reduced oral intake, and persistent nutritional deficits, while structured nutritional support after ICU discharge remains inconsistently implemented.

Conclusions

Current evidence increasingly supports an individualized, phase-adapted approach to nutritional therapy rather than uniform early aggressive calorie and protein targets. Nutritional strategies should consider illness severity, metabolic phase, organ dysfunction, gastrointestinal tolerance, and recovery trajectory. Further studies are needed to define optimal nutritional targets during post-ICU recovery. An evidence-informed practical framework for phase-adapted nutritional therapy is proposed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Critical IllnessDietary ProteinsNutritional SupportCritical CareNutrition TherapyHumansIntensive Care UnitsAdaptation, PhysiologicalEnergy Intake

Stichwörter der Autor:innen

ICU protein provisionanabolic resistancecritical care nutritioncritical illnessphase-adapted nutritionpost-intensive care syndrome

Substanzen

Dietary Proteins

Autor:innen und Institutionen

  • Department of Anesthesiology and Intensive Care Medicine, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540103 Târgu Mureș, Romania.
  • Department of Pathophysiology, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540136 Târgu Mureș, Romania.
  • Department of Genetics, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.
  • Orthopedic Surgery and Traumatology Service, Marina Baixa Hospital, Av. Alcade En Jaume Botella Mayor, 03570 Villajoyosa, Spain.
  • Doctoral School of Medicine and Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540142 Târgu Mureș, Romania.
  • Department of Public Health and Health Management, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, 540139 Târgu Mureș, Romania.

ORCID-Profile: Mircea Stoian, Adina Stoian, Claudia Bănescu, Sergio Rares Bandilă Bandilă, Leonard Azamfirei

Zitieren

APA

Stoian, M., Stoian, A., Bănescu, C., Bandilă, S. R. B., Danilesco, A., Finta, H., & Azamfirei, L. (2026). Phase-Specific Nutritional Therapy in Critical Illness: When Protein May Help and When It May Harm, from Acute Metabolic Adaptation to Post-ICU Recovery. Nutrients, 18(17), 2840. https://doi.org/10.3390/nu18172840

Vancouver

Stoian M, Stoian A, Bănescu C, Bandilă SRB, Danilesco A, Finta H, et al. Phase-Specific Nutritional Therapy in Critical Illness: When Protein May Help and When It May Harm, from Acute Metabolic Adaptation to Post-ICU Recovery. Nutrients. 2026;18(17):2840. doi:10.3390/nu18172840

BibTeX
@article{Stoian2026,
  author = {Stoian, Mircea and Stoian, Adina and Bănescu, Claudia and Bandilă, Sergio Rares Bandilă and Danilesco, Alina and Finta, Hajnal and Azamfirei, Leonard},
  title = {Phase-Specific Nutritional Therapy in Critical Illness: When Protein May Help and When It May Harm, from Acute Metabolic Adaptation to Post-ICU Recovery},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {17},
  pages = {2840},
  doi = {10.3390/nu18172840}
}
Kostenlos starten →